Abu Safana Biswas

Abu Safana Biswas

Auto-generated profile, based on publicly available information

Abu Safana Biswas

Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education& Research (JSS AHER), Mysuru, Karnataka, India

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2026 in Current Analytical Chemistry
Verified
Journal Article
Closed access
CSChiriki Devi Sri
Chiriki Devi Sri
PRPrashantha B R
Prashantha B R
BGB M Gurupadayya
B M Gurupadayya
ASArun Kumar Sethu
Arun Kumar Sethu
MPMounika Peddaguravagari
Mounika Peddaguravagari
SBSandeep Bodduna
Sandeep Bodduna
Introduction: Chiral Dihydropyrimidines (DHPMs) exhibit diverse biological activities depending on their stereochemistry, necessitating efficient enantioselective separation and accurate absolute configuration determination. This research focused on two chiral DHPM derivatives: 4-(3,4- dichlorophenyl)-6-methyl-2-oxo-N-(o-tolyl)-1,2,3,4-tetrahydropyrimidine-5-carboxamide (DHPM-1) and 6-methyl-2-oxo-N-(o-tolyl)-4-(p-tolyl)-1,2,3,4-tetrahydropyrimidine-5-carboxamide (DHPM-2). The study aimed to synthesize these compounds, resolve their enantiomers, determine their absolute configurations, and explore the utility of molecular docking for chiral discrimination, while also assessing the environmental impact of the analytical methods. Methods: Condensation reactions were used to create the target DHPMs. For enantiomeric separation, preparative-scale High-Performance Liquid Chromatography (HPLC) was utilized with Chiral ART Cellulose SC and SZ columns (250 x 30mm, 5μm, 30 mL/min flow rate). Circular Dichroism (CD) and Specific Optical Rotation (SOR) spectroscopy were used to determine the absolute configurations of the separated enantiomers. The potential of this method to differentiate between enantiomers based on their binding to relevant targets was assessed using molecular docking simulations. GAPI and AGREE software were used to evaluate the environmental sustainability of the analytical methods. Results: The enantiomers of DHPM-1 and DHPM-2 were successfully separated by preparative HPLC. The definitive assignment of their absolute configurations was made possible through the analysis of CD spectra and SOR values. Using differences in binding affinities and orientations within the binding pockets, molecular docking simulations successfully distinguished between the enantiomeric pairs. The environmental impact of the analytical processes was thoroughly assessed by the GAPI and AGREE analysis. Discussion: Molecular docking, which reveals stereochemical preferences, is a useful addition to chiral discrimination. The evaluation of analytical methodologies’ greenness directs the creation of ecologically responsible and sustainable actions. Lastly, enantiomerically pure DHPMs can only be obtained using chiral HPLC. Conclusion: This research successfully synthesized and resolved the enantiomers of two chiral DHPM derivatives. The absolute configurations were determined using spectroscopic methods, and molecular docking demonstrated its utility in distinguishing between enantiomers. The environmental evaluation of the analytical methods contributes to the advancement of sustainable chiral analysis. Conclusion: These findings enhance the understanding of asymmetric synthesis and chiral resolution of DHPMs, facilitating the development of novel, stereochemically defined compounds with potential therapeutic applications.

18 March 2025
Verified
Book Chapter
Closed access
Rizwan AhamadRizwan Ahamad
Rizwan Ahamad
SPSadma Parveen
Sadma Parveen
ABAbu Safana Biswas
Abu Safana Biswas
AAAyman Alameen
Ayman Alameen

22 January 2026 in Current Drug Research Reviews
Verified
Journal Article
Closed access
SSSheikh Muhammad Suhail
Sheikh Muhammad Suhail
AAAmit Anand
Amit Anand
ABAbu Safana Biswas
Abu Safana Biswas
SASayeed Ahmad
Sayeed Ahmad
SMSanthepete Nanjundiah Manjula
Santhepete Nanjundiah Manjula
KMKenganora Mruthunjaya
Kenganora Mruthunjaya
Syzygium cumini L., commonly known as Java plum or black plum, has been extensively studied for its pharmacological properties, particularly its antioxidant, anti-inflammatory, and anticancer potential. This review provides a comprehensive insight into the bioactive constituents of S. cumini, including polyphenols, flavonoids, tannins, and anthocyanins, which contribute to its therapeutic efficacy. The antioxidant potential of S. cumini plays a crucial role in mitigating oxidative stress-related disorders by neutralizing free radicals and enhancing endogenous defense mechanisms. Its anti-inflammatory properties, mediated through the modulation of key signalling pathways such as NF-κB and COX-2, highlight its potential in managing chronic inflammatory diseases. Furthermore, emerging evidence suggests that S. cumini exhibits anticancer effects by inducing apoptosis, inhibiting cancer cell proliferation, and modulating oncogenic pathways. A detailed analysis using in-vitro and in-vivo studies has further elucidated the molecular mechanisms underlying these bioactivities, offering promising directions for future research and therapeutic applications. This review aims to consolidate current knowledge on the pharmacological potential of S. cumini, emphasizing its relevance in the development of novel therapeutic agents.

7 September 2025 in International Journal of Applied Pharmaceutics
Verified
Journal Article
Open access
PDF file
ABABU Safana Biswas
ABU Safana Biswas
GRGanavi Bethanagere Ramesha
Ganavi Bethanagere Ramesha
KKKamsagara Linganna Krishna
Kamsagara Linganna Krishna
BBBharat Jayaprakash Byalahunashi
Bharat Jayaprakash Byalahunashi
SMSeema Mehdi
Seema Mehdi
SPSuman Pathak
Suman Pathak
Myocardial infarction (MI), a leading cause of death globally, is primarily caused by coronary artery blockage and the resulting myocardial ischemia. The epidemiology, molecular processes, clinical biomarkers, and treatment approaches of MI are all included in this review. In addition, the traditional antiplatelet treatments and new natural inhibitors such as disintegrin from snake venom, special attention is given to the platelet integrin αIIbβ3 receptor, whose crucial function in MI pathogenesis is reviewed. Several studies conducted between 2018 and 2023 demonstrated that αIIbβ3 plays a crucial role in mediating fibrinogen-dependent platelet aggregation and thrombus stability after plaque rupture. Using αIIbβ3 inhibitors during high-risk percutaneous coronary intervention (PCI) was justified by these findings. The recent studies done in 2024–2025 have broadened our understanding by showing that αIIbβ3 has a role in leukocyte-platelet interactions, thrombosis, inflammatory signalling, and plaque progression, indicating that its functions extend beyond hemostasis. Vascular damage and repair are reviewed in connection with important molecular pathways implicated in MI development, such as PI3K/Akt, Notch, NLRP3/Caspase-1/IL-1β, TLR4/MYD88/NF-κB, JAK/STAT, and TGF-β/SMADs. The growing clinical significance of diagnostic biomarkers such as troponins, CK-MB, VEGF-A₁₆₅b, and MMP-28 is underlined. In summary, αIIbβ3 continues to play a key role in thrombus formation by binding fibrinogen and encouraging platelet aggregation; however, recent data suggest that it also plays a role in vascular inflammation and atherogenesis, making it a viable target for the treatment of MI both acutely and over the long term.

29 September 2025 in 3 Biotech
Verified
Journal Article
Closed access
ABAbu Safana Biswas
Abu Safana Biswas
RSRajeshwari Selvaraj
Rajeshwari Selvaraj
KKKamsagara Linganna Krishna
Kamsagara Linganna Krishna
GRGanavi Bethanagere Ramesha
Ganavi Bethanagere Ramesha
BBBharat Jayaprakash Byalahunashi
Bharat Jayaprakash Byalahunashi
SPSuman Pathak
Suman Pathak